pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT04334941: Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Extensive Stage Lung Small Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07369154: 52-week Open Label Safety-Tolerability Study

Sponsor: LB Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06956105: Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents

Sponsor: Neurovalens Ltd.. Phase: NA. Conditions: General Anxiety Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT05164705: Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia

Sponsor: Northwestern University. Phase: NA. Conditions: Healthy Brain Perfusion

full page →ctgov ↗
›RECRUITINGphase readoutNCT06014905: Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Sponsor: Javier Villaneuva-Meyer, MD. Phase: PHASE1. Conditions: Meningioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT01280994: Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

Sponsor: Bastiaan Driehuys. Phase: PHASE2. Conditions: Interstitial Lung Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05942066: Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications

Sponsor: Tethis S.p.A.. Phase: . Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT04109456: IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Sponsor: InxMed (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: Metastatic Melanoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07292922: Digital-supported Orofacial Myofunctional Therapy in OSA

Sponsor: Hong Kong Metropolitan University. Phase: NA. Conditions: Obstructive Sleep Apnea (OSA)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07458451: Effect of Nature Sounds During Dental Filling on Anxiety in Older Adults

Sponsor: EMRE ERKAL. Phase: NA. Conditions: Dental Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT05754151: Mobile CBT for Middle Aged and Older Adults

Sponsor: Weill Medical College of Cornell University. Phase: NA. Conditions: Anxiety Disorders and Symptoms, Depressive Symptoms, Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT07223229: Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.. Phase: PHASE2. Conditions: Non-segmental Vitiligo

full page →ctgov ↗
›COMPLETEDphase readoutNCT02563431: Multi-disciplinary Prevention Program

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07420231: Evaluation of the Synergistic Effect of Combining a Prebiotic and a Postbiotic on Intestinal Discomfort

Sponsor: Université Catholique de Louvain. Phase: NA. Conditions: Intestinal Discomfort, Abdominal Pain/ Discomfort

full page →ctgov ↗
›RECRUITINGphase readoutNCT07475702: Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y Sol)

Sponsor: San Francisco State University. Phase: NA. Conditions: Help-Seeking Behavior, Pre-exposure Prophylaxis Use, Condomless Sex, Risky Health Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT07359053: MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

Sponsor: Shanghai 6th People's Hospital. Phase: PHASE2. Conditions: Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07411053: The Effects of EMS-Combined Body Awareness Exercises on Non-Specific Low Back Pain

Sponsor: Recep Tayyip Erdogan University. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07513753: Focal Vibration Therapy in Post-stroke Shoulder Pain

Sponsor: University of Foggia. Phase: NA. Conditions: Stroke, Hemiplegic Shoulder Pain, Chronic Stroke Survivors

full page →ctgov ↗
›COMPLETEDphase readoutNCT02425345: Women's Health Initiative Strong and Healthy Study

Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Myocardial Infarction, Stroke, Cardiovascular Mortality, Hip Fractures, Falls, Mortality, Venous Thromboembolic Event, Peripheral Artery Disease, Physical Function, Coronary Revascularization, Mobility and Independence, Clinical (Non-hip) Fractures, Sleep, Depressive Symptoms

full page →ctgov ↗
›RECRUITINGphase readoutNCT05815745: "Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)

Sponsor: Imperial College London. Phase: NA. Conditions: Bradycardia, Pacing, Right Ventricular Pacing, His Bundle Pacing, Left Bundle Branch Area Pacing

full page →ctgov ↗
›COMPLETEDphase readoutNCT05293145: AVANCE-Houston Building Futures Program Evaluation

Sponsor: Midwest Evaluation & Research. Phase: NA. Conditions: Youth

full page →ctgov ↗
›TERMINATEDphase readoutNCT00678145: Mechanisms of Hypoglycemia Associated Autonomic Failure

Sponsor: Albert Einstein College of Medicine. Phase: PHASE2. Conditions: Diabetes Mellitus, Hypoglycemia, Autonomic Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07365345: Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

Sponsor: Air Force Military Medical University, China. Phase: NA. Conditions: Transcatheter Aortic Valve Replacement (TAVR), Hemodynamic Stability, Anesthesia Induction, Electro-acupuncture

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06086145: Biomarker-estimated Flavanol Intake in Davis (FID)

Sponsor: University of California, Davis. Phase: . Conditions: Healthy, Diet, Adults

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06039345: Shoulder RFA Pilot Study

Sponsor: University of Utah. Phase: . Conditions: Shoulder Pain, Rotator Cuff Injuries

full page →ctgov ↗
›COMPLETEDphase readoutNCT07412080: EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

Sponsor: Eddingpharm (Zhuhai) Co., Ltd.. Phase: PHASE1. Conditions: Healthy Adult Male and Female Volunteers, Mild Dyslipidemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07341685: Comparison of Pain, Physical, and Psychosocial Parameters in Women With and Without Primary Dysmenorrhea

Sponsor: Izmir Democracy University. Phase: NA. Conditions: Primary Dysmenorrhea

full page →ctgov ↗
›COMPLETEDphase readoutNCT07684443: Oral Mucosal Pressure Injuries and Endotracheal Tube Dislodgement Among Elderly Trauma Patients

Sponsor: Norther Private Collage of Nursing. Phase: NA. Conditions: Elderly, Trauma ICU Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT07284043: A Mass Balance Study of [14C] MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism

Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd.. Phase: PHASE1. Conditions: Hemodialysis Subjects With Secondary Hyperparathyroidism

full page →ctgov ↗
›RECRUITINGphase readoutNCT03384108: In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells

Sponsor: Mayo Clinic. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06756308: A Study of Enasidenib in People With T-Cell Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: T-cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06959225: Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

Sponsor: Incyte Corporation. Phase: PHASE3. Conditions: Hidradenitis Suppurativa

full page →ctgov ↗
›RECRUITINGphase readoutNCT07659925: Periodization-Based Strength Exercise Training in İndividuals With Type 2 Diabetes

Sponsor: Baskent University. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07323225: Neural Mobilization and Capsular Stretching in Adhesive Capsulitis

Sponsor: Prince Sattam Bin Abdulaziz University. Phase: NA. Conditions: Adhesive Capsulitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05006976: A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

Sponsor: Nordlandssykehuset HF. Phase: NA. Conditions: Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue, Pain, Occupational Exposure, Work Related Stress, Workplace Bullying, Employment, Sickness Absence, Return to Work

full page →ctgov ↗
›COMPLETEDphase readoutNCT07619976: Effects of New Zealand Blackcurrant Supplementation on Exercise and Cognitive Performance in Resistance-Trained Adults

Sponsor: Jacksonville State University. Phase: NA. Conditions: Resistance Exercise Performance, Cognitive Function, Anaerobic Performance, Dietary Supplementation Athletic Performance

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07616076: Olfactory Communication in the First Days of Life: From Chemical Mechanisms to Improved Breastfeeding

Sponsor: Centre Hospitalier Universitaire Dijon. Phase: . Conditions: Mother Who Has Given Birth to a Singleton Newborn, Mother-newborn Dyad, Singleton Newborn

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07670117: HAIQU (Hospital AIr QUality)

Sponsor: Mayo Clinic. Phase: NA. Conditions: Acute Respiratory Tract Infection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04543617: A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Esophageal Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06732440: Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation

Sponsor: Creighton University. Phase: NA. Conditions: Vestibular Hypofunction, Bilateral Vestibular Hypofunction, Presbyvestibulopathy, Healthy Controls

full page →ctgov ↗
›RECRUITINGphase readoutNCT06535568: Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS. Phase: NA. Conditions: Coronary Disease, Heart Diseases, Cardiovascular Diseases, Myocardial Ischemia, Atherosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Coronary Artery Disease, Acute Coronary Syndrome, Coronary Stenosis, Molecular Mechanisms of Pharmacological Action, Enzyme Inhibitors, MTOR Inhibitors, Protein Kinase Inhibitors, Physiological Effects of Drugs, Immunosuppressive Agents, Antineoplastic Agents, High Bleeding Risk, Single Antiplatelet Therapy, Dual Antiplatelet Therapy, Cyclooxygenase Inhibitors, P2Y12 Inhibitor, Platelet Aggregation Inhibitors, Aspirin, Clopidogrel

full page →ctgov ↗
›RECRUITINGphase readoutNCT07224750: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Sponsor: City of Hope Medical Center. Phase: . Conditions: Hepatocellular Carcinoma (HCC), Cholangiocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer (GC), Colorectal Cancer Screening

full page →ctgov ↗
›RECRUITINGphase readoutNCT00162474: Determinants of Warfarin Metabolism

Sponsor: Hadassah Medical Organization. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Sponsor: Second Xiangya Hospital of Central South University. Phase: . Conditions: Type1diabetes, Diabetes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07428018: Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib

Sponsor: Mario Negri Institute for Pharmacological Research. Phase: PHASE2. Conditions: Breast Cancer, HER2 + Breast Cancer, HR Positive, Neoadjuvant Therapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07579390: Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)

Sponsor: Helsinki University Central Hospital. Phase: NA. Conditions: Acute Kidney Failure, Renal Replacement Therapy for Acute Kidney Injury in ICU, Sedation in Intensive Care Unit Patients, Sedation in the ICU, Sedation in Intensive Care, Blood Pressure, Mean Arterial Pressure Targets, Temperature, Fever, Resuscitated Sudden Cardiac Death, Out of Hospital Cardiac Arrest, Cardiac Arrest (CA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07607197: Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: PHASE1. Conditions: Kidney Failure, Chronic, Kidney Transplantation, Alloimmunization, HLA Sensitization, End Stage Cronic Kidney Disease, Highly Sensitized Patients Awaiting Kidney Transplant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07222410: Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Sponsor: Fisher and Paykel Healthcare. Phase: NA. Conditions: COPD

full page →ctgov ↗
›RECRUITINGphase readoutNCT07052513: Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery

Sponsor: M2RLAB SL. Phase: PHASE2. Conditions: Acute Kidney Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT07330713: Platelet-Rich Plasma for Acute Nonarteritic Anterior Ischemic Optic Neuropathy: A Prospective Randomized Controlled Study

Sponsor: Uludag University. Phase: NA. Conditions: Nonarteritic Anterior Ischemic Optic Neuropathy

full page →ctgov ↗
← prev
page 98 of 106
next →